Director/PDMR Shareholding | 26-Apr-2024 | 09:17 | RNS |
Holding(s) in Company | 25-Apr-2024 | 15:41 | RNS |
Holding(s) in Company | 17-Apr-2024 | 15:30 | RNS |
Holding(s) in Company | 04-Apr-2024 | 15:17 | RNS |
Director/PDMR and PCA Shareholding | 02-Apr-2024 | 14:47 | RNS |
Total Voting Rights | 28-Mar-2024 | 17:04 | RNS |
Director/PDMR Shareholding | 18-Mar-2024 | 12:35 | RNS |
Proposed acquisition of Peters Surgical | 13-Mar-2024 | 07:03 | RNS |
Unaudited Preliminary Results | 13-Mar-2024 | 07:03 | RNS |
Block listing Interim Review | 12-Mar-2024 | 07:00 | RNS |
Full Year Trading Update | 10-Jan-2024 | 07:00 | RNS |
Total Voting Rights | 30-Nov-2023 | 17:11 | RNS |
Total Voting Rights | 31-Oct-2023 | 17:02 | RNS |
US LiquiBand® distribution agreements... | 25-Oct-2023 | 07:00 | RNS |
Director/PDMR Shareholding | 02-Oct-2023 | 07:01 | RNS |
Currency | UK Pounds |
Share Price | 185.80p |
Change Today | -0.80p |
% Change | -0.43 % |
52 Week High | 258.00 |
52 Week Low | 177.20 |
Volume | 203,266 |
Shares Issued | 217.34m |
Market Cap | £403.82m |
RiskGrade | 156 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 4 |
Buy | 2 |
Neutral | 2 |
Sell | 1 |
Strong Sell | 0 |
Total | 9 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 30-May-24 | 28-Sep-23 |
Paid | 21-Jun-24 | 27-Oct-23 |
Amount | 1.66p | 0.70p |
Time | Volume / Share Price |
16:35 | 23,290 @ 185.80p |
16:35 | 53 @ 185.80p |
16:35 | 276 @ 185.80p |
16:35 | 373 @ 185.80p |
16:35 | 66 @ 185.80p |
CEO | A Christopher (Chris) Meredith |
CFO | Eddie Johnson |
Chair | Liz Shanahan |
You are here: research